UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

24 May 2024

Acquisition of own shares

Read More
23 May 2024

UCB announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa

Read More
17 May 2024

Transparency notification Wellington

Read More
17 May 2024

Acquisition of own shares

Read More
14 May 2024

New data published in the Journal of Neurology show clinically meaningful improvement of fatigue in generalized myasthenia gravis (gMG) with ZILBRYSQ[®]▼ (zilucoplan)

Read More
10 May 2024

Acquisition of own shares

Read More

Stay up-to-date on the latest news and information from UCB